Lim Hae Gyun, Liu Hsiao-Chuan, Yoon Chi Woo, Jung Hayong, Kim Min Gon, Yoon Changhan, Kim Hyung Ham, Shung K Kirk
Department of Creative IT Engineering, Pohang University of Science and Technology, Pohang, 37673 Republic of Korea.
NIH Resource Center for Medical Ultrasonic Transducer Technology and Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089 USA.
Microsyst Nanoeng. 2020 Jun 1;6:39. doi: 10.1038/s41378-020-0150-6. eCollection 2020.
Advancements in diagnostic systems for metastatic cancer over the last few decades have played a significant role in providing patients with effective treatment by evaluating the characteristics of cancer cells. Despite the progress made in cancer prognosis, we still rely on the visual analysis of tissues or cells from histopathologists, where the subjectivity of traditional manual interpretation persists. This paper presents the development of a dual diagnosis and treatment tool using an in vitro acoustic tweezers platform with a 50 MHz ultrasonic transducer for label-free trapping and bursting of human breast cancer cells. For cancer cell detection and classification, the mechanical properties of a single cancer cell were quantified by single-beam acoustic tweezers (SBAT), a noncontact assessment tool using a focused acoustic beam. Cell-mimicking phantoms and agarose hydrogel spheres (AHSs) served to standardize the biomechanical characteristics of the cells. Based on the analytical comparison of deformability levels between the cells and the AHSs, the mechanical properties of the cells could be indirectly measured by interpolating the Young's moduli of the AHSs. As a result, the calculated Young's moduli, i.e., 1.527 kPa for MDA-MB-231 (highly invasive breast cancer cells), 2.650 kPa for MCF-7 (weakly invasive breast cancer cells), and 2.772 kPa for SKBR-3 (weakly invasive breast cancer cells), indicate that highly invasive cancer cells exhibited a lower Young's moduli than weakly invasive cells, which indicates a higher deformability of highly invasive cancer cells, leading to a higher metastasis rate. Single-cell treatment may also be carried out by bursting a highly invasive cell with high-intensity, focused ultrasound.
在过去几十年中,转移性癌症诊断系统的进步通过评估癌细胞特征,在为患者提供有效治疗方面发挥了重要作用。尽管在癌症预后方面取得了进展,但我们仍然依赖病理学家对组织或细胞的视觉分析,而传统手工解读的主观性依然存在。本文介绍了一种双诊断和治疗工具的开发,该工具使用带有50MHz超声换能器的体外声镊平台,用于对人乳腺癌细胞进行无标记捕获和破裂。对于癌细胞的检测和分类,单束声镊(SBAT)对单个癌细胞的力学特性进行了量化,SBAT是一种使用聚焦声束的非接触评估工具。细胞模拟体模和琼脂糖水凝胶球(AHSs)用于标准化细胞的生物力学特性。基于细胞与AHSs之间变形性水平的分析比较,通过内插AHSs的杨氏模量可以间接测量细胞的力学特性。结果,计算得到的杨氏模量,即MDA-MB-231(高侵袭性乳腺癌细胞)为1.527kPa,MCF-7(低侵袭性乳腺癌细胞)为2.650kPa,SKBR-3(低侵袭性乳腺癌细胞)为2.772kPa,表明高侵袭性癌细胞的杨氏模量低于低侵袭性细胞,这表明高侵袭性癌细胞具有更高的变形性,导致更高的转移率。单细胞治疗也可以通过用高强度聚焦超声使高侵袭性细胞破裂来进行。